Evaluate the Effect of Elimune Capsules

Inclusion Criteria

• •1. Subject voluntarily agrees to participate in this study and signs an IRB-approved informed consent prior to performing any of the screening procedures.
• •2. Males and females at least 18 years of age.
• •3. Except for plaque psoriasis with or without arthritis, subject is in generally good health.
• •4. Subject exhibits acutely active at least moderate to severe plaque-type psoriasis (\> 5% BSA) with or without arthritis.
• •5. Non-pregnant, non-lactating females of childbearing potential who agree to use medically acceptable forms of birth control (abstinence, hormonal contraceptives, diaphragm with spermicide, condom with spermicide, or intrauterine device) throughout the study or females of non-childbearing potential (surgically sterile \[hysterectomy or bilateral tubal ligation\] or post-menopausal ≥ 1 year). A negative urine pregnancy test must be confirmed at screening for all female subjects who are not surgically sterile.
• •6. Non-smokers (or other nicotine use) as determined by history (no nicotine use over the past year).
• •7. Subject is willing and able to cooperate to the extent required by the protocol.